Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). HAVN Life Sciences's share price for the quarter that ended in Jan. 2023 was C$0.045. HAVN Life Sciences's Shares Outstanding (EOP) for the quarter that ended in Jan. 2023 was 14.74 Mil. Therefore, HAVN Life Sciences's market cap for the quarter that ended in Jan. 2023 was C$0.66 Mil.
HAVN Life Sciences's quarterly market cap
declined
from Jul. 2022 (C$8.52 Mil) to Oct. 2022 (C$1.06 Mil) and
declined
from Oct. 2022 (C$1.06 Mil) to Jan. 2023 (C$0.66 Mil).
HAVN Life Sciences's annual market cap
increased
from Apr. 2020 (C$0.00 Mil) to Apr. 2021 (C$76.42 Mil) but then
declined
from Apr. 2021 (C$76.42 Mil) to Apr. 2022 (C$10.70 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. HAVN Life Sciences's Enterprise Value for Today is C$0.45 Mil.
HAVN Life Sciences Market Cap Historical Data
The historical data trend for HAVN Life Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of HAVN Life Sciences's Market Cap
For the Biotechnology subindustry, HAVN Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HAVN Life Sciences's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HAVN Life Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where HAVN Life Sciences's Market Cap falls into.
HAVN Life Sciences Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
HAVN Life Sciences's Market Cap for the fiscal year that ended in Apr. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAVN Life Sciences (XCNQ:HAVN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
HAVN Life Sciences Market Cap Related Terms
Thank you for viewing the detailed overview of HAVN Life Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
HAVN Life Sciences (XCNQ:HAVN) Business Description
HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:HAVN has been successfully added to your 